|1.||Bartos, Ales: 1 article (08/2014)|
|2.||Kristofikova, Zdena: 1 article (08/2014)|
|3.||Gazova, Zuzana: 1 article (08/2014)|
|4.||Siposova, Katarina: 1 article (08/2014)|
|5.||Sirova, Jana: 1 article (08/2014)|
|6.||Kotoucova, Jolana: 1 article (08/2014)|
|7.||Ripova, Daniela: 1 article (08/2014)|
|8.||Ricny, Jan: 1 article (08/2014)|
|9.||Mezencev, R: 1 article (01/2003)|
|10.||Kutschy, P: 1 article (01/2003)|
01/01/2003 - "cyclobrassinin, spirobrassinin, brassinin) also exhibited cancer chemopreventive activity in models of mammary and skin carcinogenesis. "
01/01/2003 - "brassinin, spirobrassinin, brassilexin, camalexin, 1-methoxyspirobrassinin, 1-methoxyspirobrassinol and methoxyspirobrassinol methyl ether) have been found to possess significant antiproliferative activity against various cancer cells and this activity is supposed to be associated with the modulation of activity of transcription factors regulating cell cycle, differentiation and apoptosis. "
08/01/2014 - "Based on the significant effect of spirobrassinin in vitro, we suggest that spirobrassinin may be of therapeutic value in multiple sclerosis. "
08/01/2014 - "Both ferrofluid and spirobrassinin evoked drops in thioflavin-T-based fluorescence; however, ferrofluid was more efficient in old controls (54-75 years old people) and spirobrassinin in multiple sclerosis patients, both compared to young controls. "
|1.||Transcription Factors (Transcription Factor)
|2.||Ethyl Ether (Ether)